Although the existing global ACE2 KO models described above exhibit some differences at baseline (body weight, BP, cardiac phenotype, etc.), their responses to cardiometabolic challenges or inflammatory insults are largely consistent, highlighting the protective roles of ACE2 in cardiovascular, pulmonary, and metabolic diseases. Here, ACE2 is linked to metabolic disease.